FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration
Clinical trial NCT01500915 · COMPLETED
Trial details
- NCT number
- NCT01500915
- Sponsor
- Institut de la Macula y la Retina
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-03-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.